| Name | Title | Contact Details |
|---|
At enGene, we are at the vanguard of a new era in genetic medicine: Our novel Dually Derivatized Oligochitosan® (DDX) gene delivery platform is designed to enable localized delivery of multiple gene cargos, including RNA and DNA, directly to mucosal tissues and other organs — potentially overcoming the limitations of viral-based gene therapies and advancing gene therapy beyond rare genetic diseases into the mainstream of clinical practice. Our breakthrough Dually Derivatized Oligochitosan® (DDX) platform opens possibilities for streamlining the use of genetic medicines in the treatment of serious diseases, especially diseases afflicting mucosal tissues. Our lead product candidate, EG-70 (detalimogene voraplasmid), is a non-viral immunotherapy in development to treat non-muscle invasive bladder cancer (NMIBC), a disease with a significant patient burden, high clinical needs, and massive healthcare system economic impact. Based on its preliminary efficacy and safety profile and ease of administration by urologists, EG-70, which is currently in a pivotal trial, can potentially benefit patients across a wide variety of clinical settings. As enGeneers, we are boldly focused on patients needs. We are a team of passionate experts with extensive experience in drug development and commercialization across oncology, respiratory, and several other therapeutic areas. Nasdaq: ENGN
Freight Trends is a firm focused on the future of our industry. Through writing (The Freight Stack, Market Currents Report) as well as consulting and advising startups!
Mindsight is an extension of your team. Our culture is built on transparency and trust, and our team is made up of extraordinary people — the kinds of people you would hire. Weve always prided ourselves in delivering the full spectrum of IT services and solutions, from design and implementation to support and management. As one of the largest Chicago IT consulting firms, thats our job, and our highly-certified engineers and process-oriented excellence have certainly been key to our success. But what really sets us apart is our straightforward and honest approach to every conversation, whether it is for a local business or a global enterprise.
EF & I Corp. is one of the leading companies in Business Services industry. EF & I Corp. is based in Tampa, FL. You can find more information on EF & I Corp. at www.eficorp.com
Bridgeway Benefit Technologies is the foremost provider for multiemployer benefits administration technology solutions. With the strength of our BASYS and ISSI platforms, we offer greater choice, enhanced capabilities and unmatched service delivery built for data security, regulatory compliance and a lower cost of ownership. Our software suites, web-based portals and hosting solutions serve the Taft-Hartley community and its millions of union members in the United States and Canada. The company provides trust fund offices, multiemployer plans and third-party administrators with a robust product suite for managing contributions, eligibility, claims processing, retirement plan administration and more.